Mitochondrial membrane protein associated neurodegenration

  • Eva C Schulte
  • Malte C Claussen
  • Angela Jochim
  • Tobias Haack
  • Monika Hartig
  • Maja Hempel
  • Holger Prokisch
  • Ursula Haun-Jünger
  • Juliane Winkelmann
  • Bernhard Hemmer
  • Annette Förschler
  • Rüdiger Ilg

Related Research units

Abstract

BACKGROUND: Recently, mutations in an open-reading frame on chromosome 19 (C19orf12) were identified as a novel genetic factor in neurodegeneration with brain iron accumulation (NBIA). Because of the mitochondrial localization of the derived protein, this variant is referred to as mitochondrial membrane protein-associated neurodegeneration with brain iron accumulation (MPAN).

METHODS/RESULTS: We describe the clinical phenotype and MRI of 3 newly identified individuals with MPAN due to either previously reported or novel homozygous or compound heterozygous genetic alterations in C19orf12.

CONCLUSIONS: MPAN is characterized by a juvenile-onset, slowly progressive phenotype with predominant lower limb spasticity, generalized dystonia, and cognitive impairment. Typical additional features include axonal motor neuropathy and atrophy of the optic nerve. MRI showed iron deposition in the globus pallidus and substantia nigra without the eye-of-the-tiger sign, which is typical for PKAN, the most frequent form of NBIA.

Bibliographical data

Original languageEnglish
ISSN0885-3185
DOIs
Publication statusPublished - 02.2013
PubMed 23436634